Close Menu

NEW YORK – University of Houston spinout Luminostics is developing a luminescent nanoparticle lateral flow platform that it believes will achieve far better performance than current commercial tests using similar technology. 

The firm's diagnostic platform in development, called Clip, uses lateral flow as the basis of its design, but its photoluminescent phosphor nanoparticle materials contribute most to the platform's potential for future deployment in testing at home, in doctors' offices, and in global health clinics, Bala Raja, the company's cofounder, said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.